Abstract
Disturbances in circulating phospholipids levels and their association with the phenotype have been observed in inflammatory disorders and allergic diseases, such as asthma. However, the role and related mechanisms of metabolites in the development of AD are rarely known. We sought to apply serum untargeted metabolomic profiling to identify pathogenic mechanisms and candidate disease biomarkers in children with AD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
